In Vitro Lung Model Market Size, Trends, Analysis, and Outlook By Type (2D Model, 3D Model), By Application (Drug discovery and toxicology studies, Physiological research, 3D Model development, Others), By End-user (Academic research institutes, Pharmaceutical and biotechnology companies, Others), by Region, Country, Segment, and Companies, 2024-2030
The global In Vitro Lung Model market size is poised to register 17.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global In Vitro Lung Model market across By Type (2D Model, 3D Model), By Application (Drug discovery and toxicology studies, Physiological research, 3D Model development, Others), By End-user (Academic research institutes, Pharmaceutical and biotechnology companies, Others).
The in vitro lung model market is witnessing significant growth driven by increasing applications in drug discovery and development, rising demand for alternative testing methods, and advancements in tissue engineering and microfluidics technologies. In vitro lung models are artificial systems designed to mimic the structure and function of the human lung, allowing researchers to study lung physiology, disease mechanisms, and drug responses in a controlled laboratory setting. Factors such as the growing need for predictive preclinical models, rising concerns about animal welfare and ethical considerations, and expanding applications in respiratory toxicology, inhalation drug delivery, and environmental health research are driving market expansion. Additionally, advancements in three-dimensional (3D) cell culture techniques, increasing use of organ-on-a-chip platforms and bioengineered lung tissues, and expanding collaborations between academia and industry to develop physiologically relevant lung models are further fueling market growth. Moreover, rising investments in respiratory disease research, growing demand for personalized medicine approaches, and expanding regulatory acceptance of in vitro lung models as predictive tools for drug safety and efficacy assessment are expected to drive market growth in the coming years. Furthermore, efforts to develop standardized assay protocols, optimize tissue culture conditions, and validate in vitro lung models for specific applications are likely to accelerate market expansion.
In Vitro Lung Model Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In Vitro Lung Model market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In Vitro Lung Model survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In Vitro Lung Model industry.
Key market trends defining the global In Vitro Lung Model demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In Vitro Lung Model Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The In Vitro Lung Model industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In Vitro Lung Model companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In Vitro Lung Model industry
Leading In Vitro Lung Model companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In Vitro Lung Model companies.
In Vitro Lung Model Market Study- Strategic Analysis Review
The In Vitro Lung Model market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The In Vitro Lung Model industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
In Vitro Lung Model Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America In Vitro Lung Model Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various In Vitro Lung Model market segments. Similarly, Strong end-user demand is encouraging Canadian In Vitro Lung Model companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico In Vitro Lung Model market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In Vitro Lung Model Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In Vitro Lung Model industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European In Vitro Lung Model market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In Vitro Lung Model Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In Vitro Lung Model in Asia Pacific. In particular, China, India, and South East Asian In Vitro Lung Model markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America In Vitro Lung Model Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In Vitro Lung Model Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In Vitro Lung Model market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In Vitro Lung Model.
In Vitro Lung Model Market Company Profiles
The global In Vitro Lung Model market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd., MIMETAS, InSphero, ATTC Global
Recent In Vitro Lung Model Market Developments
The global In Vitro Lung Model market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In Vitro Lung Model Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
2D Model
3D Model
By Application
Drug discovery and toxicology studies
Physiological research
3D Model development
Others
By End-User
Academic research institutes
Pharmaceutical and biotechnology companies
Others
Geographical Segmentation:
Epithelix
MATTEK
Lonza
Emulate
AlveoliX AG
Nortis
CN Bio Innovations Ltd.
MIMETAS
InSphero
ATTC Global
Formats Available: Excel, PDF, and PPT
The in vitro lung model market is witnessing significant growth driven by increasing applications in drug discovery and development, rising demand for alternative testing methods, and advancements in tissue engineering and microfluidics technologies. In vitro lung models are artificial systems designed to mimic the structure and function of the human lung, allowing researchers to study lung physiology, disease mechanisms, and drug responses in a controlled laboratory setting. Factors such as the growing need for predictive preclinical models, rising concerns about animal welfare and ethical considerations, and expanding applications in respiratory toxicology, inhalation drug delivery, and environmental health research are driving market expansion. Additionally, advancements in three-dimensional (3D) cell culture techniques, increasing use of organ-on-a-chip platforms and bioengineered lung tissues, and expanding collaborations between academia and industry to develop physiologically relevant lung models are further fueling market growth. Moreover, rising investments in respiratory disease research, growing demand for personalized medicine approaches, and expanding regulatory acceptance of in vitro lung models as predictive tools for drug safety and efficacy assessment are expected to drive market growth in the coming years. Furthermore, efforts to develop standardized assay protocols, optimize tissue culture conditions, and validate in vitro lung models for specific applications are likely to accelerate market expansion.
In Vitro Lung Model Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In Vitro Lung Model market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In Vitro Lung Model survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In Vitro Lung Model industry.
Key market trends defining the global In Vitro Lung Model demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In Vitro Lung Model Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The In Vitro Lung Model industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In Vitro Lung Model companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In Vitro Lung Model industry
Leading In Vitro Lung Model companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In Vitro Lung Model companies.
In Vitro Lung Model Market Study- Strategic Analysis Review
The In Vitro Lung Model market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The In Vitro Lung Model industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
In Vitro Lung Model Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America In Vitro Lung Model Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various In Vitro Lung Model market segments. Similarly, Strong end-user demand is encouraging Canadian In Vitro Lung Model companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico In Vitro Lung Model market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In Vitro Lung Model Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In Vitro Lung Model industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European In Vitro Lung Model market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In Vitro Lung Model Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In Vitro Lung Model in Asia Pacific. In particular, China, India, and South East Asian In Vitro Lung Model markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America In Vitro Lung Model Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In Vitro Lung Model Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In Vitro Lung Model market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In Vitro Lung Model.
In Vitro Lung Model Market Company Profiles
The global In Vitro Lung Model market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd., MIMETAS, InSphero, ATTC Global
Recent In Vitro Lung Model Market Developments
The global In Vitro Lung Model market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In Vitro Lung Model Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
2D Model
3D Model
By Application
Drug discovery and toxicology studies
Physiological research
3D Model development
Others
By End-User
Academic research institutes
Pharmaceutical and biotechnology companies
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Epithelix
MATTEK
Lonza
Emulate
AlveoliX AG
Nortis
CN Bio Innovations Ltd.
MIMETAS
InSphero
ATTC Global
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 In Vitro Lung Model Market Overview and Key Findings, 2024
1.2 In Vitro Lung Model Market Size and Growth Outlook, 2021- 2030
1.3 In Vitro Lung Model Market Growth Opportunities to 2030
1.4 Key In Vitro Lung Model Market Trends and Challenges
1.4.1 In Vitro Lung Model Market Drivers and Trends
1.4.2 In Vitro Lung Model Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In Vitro Lung Model Companies
2. IN VITRO LUNG MODEL MARKET SIZE OUTLOOK TO 2030
2.1 In Vitro Lung Model Market Size Outlook, USD Million, 2021- 2030
2.2 In Vitro Lung Model Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN VITRO LUNG MODEL MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN VITRO LUNG MODEL MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
2D MODEL
3D MODEL
By Application
Drug discovery and toxicology studies
Physiological research
3D MODEL DEVELOPMENT
Others
By End-User
Academic research institutes
Pharmaceutical and biotechnology companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In Vitro Lung Model Market, 2025
5.2 Asia Pacific In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In Vitro Lung Model Market, 2025
5.5 Europe In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.6 Europe In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In Vitro Lung Model Market, 2025
5.8 North America In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.9 North America In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In Vitro Lung Model Market, 2025
5.11 South America Pacific In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.12 South America In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In Vitro Lung Model Market, 2025
5.14 Middle East Africa In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In Vitro Lung Model Market Size Outlook and Revenue Growth Forecasts
6.2 US In Vitro Lung Model Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In Vitro Lung Model Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In Vitro Lung Model Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In Vitro Lung Model Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In Vitro Lung Model Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In Vitro Lung Model Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In Vitro Lung Model Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In Vitro Lung Model Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In Vitro Lung Model Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In Vitro Lung Model Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In Vitro Lung Model Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In Vitro Lung Model Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In Vitro Lung Model Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In Vitro Lung Model Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In Vitro Lung Model Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In Vitro Lung Model Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In Vitro Lung Model Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In Vitro Lung Model Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In Vitro Lung Model Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In Vitro Lung Model Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In Vitro Lung Model Industry Drivers and Opportunities
7. IN VITRO LUNG MODEL MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN VITRO LUNG MODEL COMPANY PROFILES
8.1 Profiles of Leading In Vitro Lung Model Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Epithelix
MATTEK
Lonza
Emulate
AlveoliX AG
Nortis
CN Bio Innovations Ltd.
MIMETAS
InSphero
ATTC Global
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 In Vitro Lung Model Market Overview and Key Findings, 2024
1.2 In Vitro Lung Model Market Size and Growth Outlook, 2021- 2030
1.3 In Vitro Lung Model Market Growth Opportunities to 2030
1.4 Key In Vitro Lung Model Market Trends and Challenges
1.4.1 In Vitro Lung Model Market Drivers and Trends
1.4.2 In Vitro Lung Model Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In Vitro Lung Model Companies
2. IN VITRO LUNG MODEL MARKET SIZE OUTLOOK TO 2030
2.1 In Vitro Lung Model Market Size Outlook, USD Million, 2021- 2030
2.2 In Vitro Lung Model Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN VITRO LUNG MODEL MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN VITRO LUNG MODEL MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
2D MODEL
3D MODEL
By Application
Drug discovery and toxicology studies
Physiological research
3D MODEL DEVELOPMENT
Others
By End-User
Academic research institutes
Pharmaceutical and biotechnology companies
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In Vitro Lung Model Market, 2025
5.2 Asia Pacific In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In Vitro Lung Model Market, 2025
5.5 Europe In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.6 Europe In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In Vitro Lung Model Market, 2025
5.8 North America In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.9 North America In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In Vitro Lung Model Market, 2025
5.11 South America Pacific In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.12 South America In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In Vitro Lung Model Market, 2025
5.14 Middle East Africa In Vitro Lung Model Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In Vitro Lung Model Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In Vitro Lung Model Market Size Outlook and Revenue Growth Forecasts
6.2 US In Vitro Lung Model Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In Vitro Lung Model Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In Vitro Lung Model Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In Vitro Lung Model Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In Vitro Lung Model Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In Vitro Lung Model Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In Vitro Lung Model Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In Vitro Lung Model Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In Vitro Lung Model Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In Vitro Lung Model Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In Vitro Lung Model Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In Vitro Lung Model Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In Vitro Lung Model Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In Vitro Lung Model Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In Vitro Lung Model Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In Vitro Lung Model Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In Vitro Lung Model Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In Vitro Lung Model Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In Vitro Lung Model Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In Vitro Lung Model Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In Vitro Lung Model Industry Drivers and Opportunities
7. IN VITRO LUNG MODEL MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN VITRO LUNG MODEL COMPANY PROFILES
8.1 Profiles of Leading In Vitro Lung Model Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Epithelix
MATTEK
Lonza
Emulate
AlveoliX AG
Nortis
CN Bio Innovations Ltd.
MIMETAS
InSphero
ATTC Global
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
